Published in Am J Clin Oncol on October 01, 1996
High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study. World J Surg Oncol (2010) 1.04
The diagnosis and treatment of oral cavity cancer. Dtsch Arztebl Int (2012) 1.00
Dementia Risk in Irradiated Patients With Head and Neck Cancer. Medicine (Baltimore) (2015) 0.79
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med (1995) 6.52
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer (1999) 5.47
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res (2000) 4.66
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 4.13
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys (1996) 3.42
Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys (1999) 2.84
Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure. J Clin Oncol (2001) 2.52
Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer (1991) 2.38
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res (2000) 2.09
Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology (1996) 1.59
c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res (1992) 1.59
A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin) Clin Cancer Res (1999) 1.54
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours. Br J Cancer (1998) 1.51
Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res (1989) 1.48
Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time. Int J Radiat Oncol Biol Phys (1990) 1.44
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res (1992) 1.44
Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology (1994) 1.43
Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res (1990) 1.43
Peripheral neurotoxicity induced by docetaxel. Neurology (1996) 1.42
Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer. Ann Oncol (1994) 1.41
Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother Oncol (1992) 1.40
Long-term remission after non-radical surgery combined with brachytherapy in an infant with a chemo-resistant rhabdomyosarcoma of the tongue. Med Pediatr Oncol (2003) 1.39
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol (1994) 1.36
Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res (1989) 1.32
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours. Br J Cancer (1996) 1.24
The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatry (1990) 1.22
Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained. J Clin Oncol (1996) 1.21
Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol (1999) 1.20
Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res (1995) 1.19
Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy. Gynecol Oncol (1988) 1.19
The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys (2001) 1.16
Prognostic significance of cathepsins B and L in primary human breast cancer. J Clin Oncol (1998) 1.12
Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer. J Natl Cancer Inst (1995) 1.12
1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med (1997) 1.11
Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology (1989) 1.10
Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09. J Natl Cancer Inst (1994) 1.07
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours. Br J Cancer (2000) 1.07
The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study. Breast Cancer Res Treat (1994) 1.07
Is the pectoralis myocutaneous flap in intraoral and oropharyngeal reconstruction outdated? Am J Surg (1996) 1.06
Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys (1999) 1.06
Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int J Cancer (1992) 1.05
Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N Engl J Med (1993) 1.05
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin. Br J Cancer (1997) 1.04
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. J Clin Oncol (1997) 1.04
Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment. Gene (1995) 1.04
Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys (1997) 1.03
Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects. Br J Cancer (1990) 1.02
Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J Clin Oncol (1993) 1.01
Quality of life assessment in laryngectomized individuals: do we need additions to standard questionnaires in specific clinical research projects? Clin Otolaryngol (2005) 1.01
Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol (1999) 1.00
TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer (1996) 1.00
Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res (1995) 0.99
The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study. Eur J Cancer (1993) 0.98
Survival after resection for carcinoma of the oesophagus. Br J Surg (1987) 0.98
The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys (1998) 0.97
Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival. Int J Cancer (1995) 0.96
Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors. J Clin Oncol (1997) 0.96
The role of radiotherapy in the treatment of bile duct carcinoma. Int J Radiat Oncol Biol Phys (1990) 0.96
[Current viewpoints in the treatment of esophageal carcinoma]. Ned Tijdschr Geneeskd (1993) 0.96
Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int J Radiat Oncol Biol Phys (1993) 0.95
Multi-institutional assessment of the Provox 2 voice prosthesis. Arch Otolaryngol Head Neck Surg (1999) 0.94
Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site. J Clin Oncol (1995) 0.94
Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer (1999) 0.94
Heterogeneous X inactivation in trophoblastic cells of human full-term female placentas. Am J Hum Genet (1999) 0.94
Winner of the "New Investigator Award" at the European Society of Hyperthermia Oncology Meeting 2007. The HYPERcollar: a novel applicator for hyperthermia in the head and neck. Int J Hyperthermia (2007) 0.93
Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br J Cancer (1994) 0.93
Continuity of information in cancer care: evaluation of a logbook. Patient Educ Couns (1997) 0.93
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors. J Clin Oncol (1997) 0.93
Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys (1990) 0.92
Wound healing of the nasal septal perichondrium in young rabbits. ORL J Otorhinolaryngol Relat Spec (1990) 0.92
Salvage or what follows the failure of a free jejunum transfer for reconstruction of the hypopharynx? J Plast Reconstr Aesthet Surg (2009) 0.92
Immediate versus delayed shoulder exercises after axillary lymph node dissection. Am J Surg (1990) 0.92
Stress and woundhealing of the cartilaginous nasal septum. Acta Otolaryngol (1989) 0.91
Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol (1988) 0.91
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer. J Steroid Biochem Mol Biol (1990) 0.90
Localized unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (1990) 0.90
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration. Eur J Cancer (1995) 0.90
Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer. Br J Cancer (1999) 0.89
The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo. J Neurol (1992) 0.89
Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study. Cancer (1998) 0.88
Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet (1993) 0.87
The influence of alcohol and smoking on the incidence of oral and oropharyngeal cancer in women. Clin Otolaryngol Allied Sci (1997) 0.87
The clinical feasibility of deep hyperthermia treatment in the head and neck: new challenges for positioning and temperature measurement. Phys Med Biol (2010) 0.86
Five days of oral topotecan (Hycamtin), a phase I and pharmacological study in adult patients with solid tumours. Eur J Cancer (1998) 0.86
Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease. Int J Cancer (1988) 0.86
Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors. Clin Cancer Res (1998) 0.86
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. J Clin Oncol (1998) 0.86
Heat and moisture exchangers as a treatment option in the post-operative rehabilitation of laryngectomized patients. Clin Otolaryngol Allied Sci (1995) 0.86
CO2-laser treatment of recurrent glottic carcinoma. Head Neck (2001) 0.85
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine. Eur J Cancer (1994) 0.85